National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ibandronate sodium
The sodium salt of ibadronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:ibandronic acid
US brand name:Boniva
Foreign brand name:Bondronate



Previous:hypertonic saline, hypoxia-activated prodrug TH-302, Hytone, I 131 monoclonal antibody CC49, IAP inhibitor HGS1029
Next:ibritumomab tiuxetan, ibuprofen, IC-GREEN, ICE regimen, Idamycin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov